Nanoparticles can be functionalized with antibodies or ligands that specifically bind to VCAM-1. This functionalization process typically involves the conjugation of these molecules to the surface of nanoparticles, enhancing their ability to specifically target cells expressing VCAM-1. Techniques such as covalent bonding and electrostatic interactions are commonly used for this purpose.
